首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
考研
The debate in rich countries about the high price of drugs is a furious and frustrating one. The controversy is already having a
The debate in rich countries about the high price of drugs is a furious and frustrating one. The controversy is already having a
admin
2022-02-27
61
问题
The debate in rich countries about the high price of drugs is a furious and frustrating one. The controversy is already having an impact on spending on drugs, suggest new figures from the QuintilesIMS Institute, a research firm. The rate of growth in spending on prescription medicines in America fell to 4. 8% in 2016, less than half the average rate of the previous two years. Michael Levesque of Moody’s, a rating agency, reckons that pressure over pricing is contributing to a deceleration in earnings growth at pharma firms. Public scrutiny constrains their flexibility over what they can charge and allows payers to get tougher.
In one area, however, earnings are expected to keep rising: cancer. Oncology is the industry’s bright spot, says Mr. Levesque. The grim fact is that two-fifths of people can now expect to get cancer in their lifetime because of rising longevity. This is one of the reasons why the number of new cancer drugs has expanded by more than 60% over the past decade. The late-phase pipeline of new medicines contains more than 600 cancer treatments. New cancer drugs are being approved more quickly.
More are arriving all the time. On May 1st, America’s Food and Drug Administration approved durvalumab (trademarked Imfinzi), a drug from AstraZeneca, a British firm, which treats cancer of the bladder. Merck of America has pembrolizumab (Keytruda); Bristol-Myers Squibb has nivolumab (Opdivo) ; and Switzerland’s Boche has atezolizumab (Tecentriq).
These checkpoint inhibitors are expected to account for much of the growth in spending on cancer medicines. Merck, in particular, has done well with Keytruda. A sense of the value of the new drugs came when Opdivo failed a key clinical trial in August last year. The market value of Bristol-Myers Squibb fell by 16%, and its shares have been in the doldrums since.
Handsome prices for cancer drugs are far less pleasing for governments, insurers and patients. Even five years ago, most newly-approved treatments had gross annual prices of more than $100,000. But the pressure on budgets has worsened with the new generation of more expensive immuno-oncology drugs, and could become more severe still if they are found to work best in combination with each other.
Making a mistake over which cancer drugs to use can be extremely costly for a payer, as illustrated by a disastrous recent attempt by Britain’s government to increase access to new cancer drugs by creating a special fund in 2010. By the time it closed in 2016, £1. 27bn ($1. 83bn) had been spent, mostly on drugs that were later shown to be ineffective for the conditions they were tried on.
Some think a better approach would be to try drugs out on patients and for payers to pay a price based on how well they work, an approach known as " value-based pricing". That would mean collecting a great deal of data from patients, which would be far from straightforward.
Some companies, such as Genentech, a biotech company owned by Roche, are trying to do just this, as are some payers including American health insurers. But however reassuring it is to know that money is going on drugs that are proven to work, it does not solve the broader problem of affordability.
选项
答案
G
解析
根据题干QuintilesIMS Institute定位到第一段,该段第二句指出:The controversy is already having an impact on spending on drugs,suggest new figures from the QuintilesIMS Institute,a research finn. 由此可知,研究公司昆泰医药信息研究所的新数据表明,这番争议已对药物开支造成影响。故答案为G。其中affects=having an impact,expense=spending。
转载请注明原文地址:https://kaotiyun.com/show/y1i4777K
0
考研英语二
相关试题推荐
Officejobsareamongthepositionshardesthitbycompumation.Wordprocessorsandtypistswillloseabout93,000jobsoverthe
TheUnitedStateshashistoricallyhadhigherratesofmarriagethanthoseofotherindustrializedcountries.Thecurrentannual
Britain’sCabinetOfficereleasedasweepingreportonthecountry’sfoodpolicy,anddeterminedthatBritonsarewastingtoomu
Shouldaleaderstrivetobelovedorfeared?Thisquestion,famouslyposedbyMachiavelli,liesattheheartofJosephNye’sne
SupposeyourcousinLiMinghasjustbeenadmittedtoauniversity.Writehim/heraletterto1)congratulatehim/her,and2)give
Many______willbeopenedupinthefutureforthosewithauniversityeducatipn.
Mosthumanbeingsactuallydecidebeforetheythink.Whenanyhumanbeing—executive,specializedexpert,orpersoninthestreet
TheGowanusCanalinBrooklynisnotoriouslytoxic.Since1869,themile-longwaterwayhasbeenadumpinggroundforgarbage,in
[A]Makingfaces[B]Showoff[C]Useacoloreffect[D]Spontaneoussnapshots[E]Creativebackground[F]Natura
随机试题
甲股份有限公司(以下简称“甲公司”)是一家上市公司,与股权投资有关的资料如下:(1)甲公司与乙公司均为增值税一般纳税人,适用的增值税税率为17%,适用的所得税税率均为25%,所得税均采用资产负债表债务法核算。2×16年1月1日,甲公司以定向增发普
政府及其所属部门滥用行政权力,强制经营者从事法律所禁止的排除或限制市场竞争的行为称为【】
患者,男,56岁。1周前右上腹部绞痛,伴恶心、呕吐,体温37.4℃,予以抗炎治疗后缓解。3天来,出现巩膜黄染,食欲缺乏,收入院。查体:腹软,无压痛,Murphy征(﹣),肝区轻叩痛。B超:胆囊10cm×5cm大小,其内可见多个点状回声,胆总管上段直径1.2
上消化道出血
肉眼血尿反复发作,最常见的肾小球疾病是
在项目目标动态控制的纠偏措施中,调整管理职能分工属于()。
下列行为没有违法的是()。
下列筹资方式中,没有筹资费用,但是财务风险较小,资本成本较高的筹资方式是()。
某案的两名凶手在以下五人中,经过公安部门的侦查后得知:①只有甲是凶手,乙才是凶手②只要丁不是凶手,丙就不是凶手③或乙是凶手,或丙是凶手④丁没有戊为帮凶,就不会作案⑤戊没有作案时间这件案件中的凶手是:
我国现场检查的原则是()。
最新回复
(
0
)